{"tool_name":"open_targets_genetics","contents":["biotools","bioschemas"],"fetched_metadata":{"biotools":{"id":"open_targets_genetics","home":"https://genetics.opentargets.org","license":"Apache-2.0","summary":"Open Targets Genetics is a robust tool highlighting variant-centric statistical evidence to allow both prioritisation of candidate causal variants at trait-associated loci and identification of potential drug targets.\n\nThe portal aggregates and merges genetic associations curated from both literature and newly-derived loci from UK Biobank, which contains functional genomics data (e.g. chromatin conformation, chromatin interactions) and quantitative trait loci (eQTLs and pQTLs). Statistical fine-mapping methods are applied across thousands of trait-associated loci to resolve association signals and to link each variant to its proximal and distal target gene(s), using a single evidence score. Integrated cross-trait colocalisation analyses and linking to detailed pharmaceutical compounds extend the capability of Open Targets Genetics to explore drug repositioning opportunities and shared genetic architecture.","addition_date":"2022-01-12T17:45:45.740339Z","last_update_date":"2022-01-14T12:51:53.614100Z","tool_type":["Database portal","Web API","Web application","Web service"]},"bioschemas":{"name":"Open Targets Genetics","home":"https://bio.tools/open_targets_genetics","license":"Apache-2.0","summary":"Open Targets Genetics is a robust tool highlighting variant-centric statistical evidence to allow both prioritisation of candidate causal variants at trait-associated loci and identification of potential drug targets.\n\nThe portal aggregates and merges genetic associations curated from both literature and newly-derived loci from UK Biobank, which contains functional genomics data (e.g. chromatin conformation, chromatin interactions) and quantitative trait loci (eQTLs and pQTLs). Statistical fine-mapping methods are applied across thousands of trait-associated loci to resolve association signals and to link each variant to its proximal and distal target gene(s), using a single evidence score. Integrated cross-trait colocalisation analyses and linking to detailed pharmaceutical compounds extend the capability of Open Targets Genetics to explore drug repositioning opportunities and shared genetic architecture.","tool_type":"sc:SoftwareApplication"}}}